Document is current
Any future updates will be listed below
-
Authors
,
Reiner, Anne S.
Lynch, Charles F.
Sisti, Julia S.
John, Esther M.
Brooks, Jennifer D.
Bernstein, Leslie
Knight, Julia A.
Hsu, Li
Concannon, Patrick
Mellemkjær, Lene
Tischkowitz, Marc
Haile, Robert W.
Shen, Ronglai
Malone, Kathleen E.
Woods, Meghan
Liang, Xiaolin
Morrow, Monica
Bernstein, Jonine L.
-
Funding
Funding for this research was provided by:
National Institutes of Health (CA097397, CA114236)
National Institutes of Health (CA008748)
- License Information
-
More Information
Article History
Received: 6 March 2017
Accepted: 23 June 2017
First Online: 19 July 2017
Ethics approval and consent to participate
: All participants gave written informed consent before enrollment, and the study protocols were approved by the institutional review boards at the University of Iowa (IRB-01), Fred Hutchinson Cancer Research Center, Cancer Prevention Institute of California, University of Southern California, Beckman Research Institute of the City of Hope, University of California at Irvine, Mount Sinai Hospital, Danish Cancer Society and Memorial Sloan Kettering Cancer Center, and by the Committee for the Protection of Human Subjects of the State of California and the ethical committee system in Denmark.
: Not applicable.
: Patrick Concannon owns stock in Amgen; Lene Mellemkjaer has an immediate family member who owns stock in Novo Nordisk and stock in Lundbeck and has an immediate family member employed at Novo Nordisk.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
